RxDoctor Payments Data

Stacie Jones

Pediatric Allergy/Immunology · Little Rock, ARNPI 1578663456

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $38,600 of the $41,050 with a category attached, or 94.0%. Aimmune Therapeutics, Inc. accounts for 92.1% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2020 at $32,102 and has fallen 97.6% since, to $786 in 2022.

$41,050in general payments, 2019–2025

Across 17 payments — averaging $2414.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aimmune Therapeutics, Inc.$38K
  • Regeneron$3K
  • Genentech USA, Inc.$66
$720,693in research payments, 2019–2025

Across 71 payments — averaging $10,151 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$549K
  • Novartis$149K
  • Aimmune Therapeutics, Inc.$13K
  • Sanofi US Services Inc.$10K

What the payments were for

  • Consulting fees$38,60094%
  • Travel & lodging$1,8444%
  • Food & beverage$6071%

General payments by program year

20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Aimmune Therapeutics, Inc.15$37,822
Regeneron1$3,163
Genentech USA, Inc.1$66

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric allergy/immunology providers in Arkansasto place this figure against a meaningful peer group, so we don't.

Other pediatric allergy/immunology in Little Rock

Where these figures come from

Is this you, or does something look wrong? →